Canada Pension Plan Investment Board
PCVX icon

Canada Pension Plan Investment Board’s Vaxcyte PCVX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$459K Sell
7,900
-3,800
-32% -$206K ﹤0.01% 1294
2026
Q1 		$680K Buy
11,700
+1,300
+13% +$70.6K ﹤0.01% 1124
2025
Q4 		$480K Buy
+10,400
New +$465K ﹤0.01% 1319

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Canada Pension Plan Investment Board's PCVX Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Vaxcyte (PCVX) stake by 32% in Q2 2026, selling an estimated $206K and leaving 7,900 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Canada Pension Plan Investment Board first reported a position in PCVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $680K in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Canada Pension Plan Investment Board held 7,900 shares of Vaxcyte worth $459K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 3,800 Vaxcyte shares in Q2 2026, an estimated $206K.
  • Vaxcyte made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1294 holding.
  • Canada Pension Plan Investment Board first reported a position in Vaxcyte in Q4 2025 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Vaxcyte position peaked at $680K in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.